Preprint Article Version 1 This version is not peer-reviewed

RBD specific B-cell Memory Responses among Vaccinated Individuals against SARS-CoV-2

Version 1 : Received: 2 August 2024 / Approved: 3 August 2024 / Online: 6 August 2024 (06:05:27 CEST)

How to cite: Athavale, A.; Gaur, A.; Ahmed, N.; Subramaniam, A.; Dandotiya, J.; Raj, S.; Upadhyay, S. K.; Samal, S.; Pandey, A. K.; Rai, R. C.; Awasthi, A. RBD specific B-cell Memory Responses among Vaccinated Individuals against SARS-CoV-2. Preprints 2024, 2024080230. https://doi.org/10.20944/preprints202408.0230.v1 Athavale, A.; Gaur, A.; Ahmed, N.; Subramaniam, A.; Dandotiya, J.; Raj, S.; Upadhyay, S. K.; Samal, S.; Pandey, A. K.; Rai, R. C.; Awasthi, A. RBD specific B-cell Memory Responses among Vaccinated Individuals against SARS-CoV-2. Preprints 2024, 2024080230. https://doi.org/10.20944/preprints202408.0230.v1

Abstract

During the last few years, the world witnessed one of the worst calamities to humankind- the COVID-19 pandemic. We also witnessed the development of vaccines at an unprecedented pace against the SARS-CoV-2- the causative agent. India was among the hard-hit countries by COVID-19, developed its indigenous vaccine and implemented vaccines developed in other countries as well. Initially, the antibody level and the neutralizing antibody titer against the pathogen were considered as the correlates of immune protection from the disease. However, the long-term protection from the pathogen was provided by the immune memory cells viz. T and B memory cells and their ability to efficiently make recall responses. In this regard, globally the research studies focused mainly on the mRNA-based vaccines. The studies on immune memory response, particularly- the B cell memory response bestowed by the vaccines given to Indians is relatively obscure. We studied the level of RBD specific memory B cells in the peripheral circulation of the study participants and the ability of B cells to secrete antigen-specific antibodies among Indians vaccinated with Covaxin (BBV152), Covishield (AZD1222), Corbevax (BECOV2D) and Sputnik Light (Gam-COVID-Vac) as well as unvaccinated individuals. Our study revealed that Corbevax and Sputnik Light conferred better antibody-secreting cell (ASC) responses.

Keywords

Receptor Binding Domain (RBD); Memory B-cell (MBC); Antibody-secreting cell (ASC); Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2); Coronavirus Disease-2019 (COVID-19)

Subject

Biology and Life Sciences, Immunology and Microbiology

Comments (0)

We encourage comments and feedback from a broad range of readers. See criteria for comments and our Diversity statement.

Leave a public comment
Send a private comment to the author(s)
* All users must log in before leaving a comment
Views 0
Downloads 0
Comments 0
Metrics 0


×
Alerts
Notify me about updates to this article or when a peer-reviewed version is published.
We use cookies on our website to ensure you get the best experience.
Read more about our cookies here.